Status:
COMPLETED
Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic Nodes
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to examine the clinical feasibility and efficacy of uing IMRT to escalate the biologically effective dose to the pelvic lymph nodes in a short course of radiation therapy....
Eligibility Criteria
Inclusion
- Prostate cancer stage T-T3
- Predicted risk of lymph node involvement \> 15%
- Gleason \> 7
Exclusion
- Distance metastases
- Use of anti-coagulant therapy
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00214136
Start Date
March 1 2005
End Date
March 1 2016
Last Update
August 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States, 53792